Trimeric Sars Spike Protein
Mouse Monoclonal Anti-SARS Spike Protein IgG |
|||
AB-15710 | Alpha Diagnostics | 20 ug | EUR 489.6 |
Human IgG antibody Laboratories manufactures the trimeric sars spike protein reagents distributed by Genprice. The Trimeric Sars Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Trimeric products are available in stock. Specificity: Trimeric Category: Sars Group: Spike Protein
SARS Spike Antibody |
||
SAB | 100ul | EUR 468 |
SARS Spike Antibody |
||
SAB | 100ul | EUR 479 |
SARS Spike Antibody |
||
SAB | 100ul | EUR 468 |
SARS Spike Antibody |
||
SAB | 100ul | EUR 479 |
SARS Spike Antibody |
||
SAB | 100ul | EUR 468 |
SARS Spike |
||
ProSpec Tany | 5µg | EUR 175 |
Description: Polyclonal Rabbit Anti SARS Spike Protein |
SARS Spike |
||
ProSpec Tany | 5µg | EUR 175 |
Description: Mouse Anti SARS Spike |
SARS-CoV-2 full-length Trimeric Spike Antigen (Indian Variant, 10mg) |
|||
BSV-COV-PR-95 | BioServUK | 10 mg | EUR 15168 |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (Indian Variant, 10mg) |
SARS-CoV-2 full-length Trimeric Spike Antigen (Californian Variant, 1mg) |
|||
BSV-COV-PR-84 | BioServUK | 1 mg | EUR 3792 |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (Californian Variant, 1mg) |
SARS-CoV-2 full-length Trimeric Spike Antigen (Californian Variant, 100ug) |
|||
BSV-COV-PR-82 | BioServUK | 100 ug | EUR 620 |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (Californian Variant, 100ug) |
SARS-CoV-2 full-length Trimeric Spike Antigen (Californian Variant, 10mg) |
|||
BSV-COV-PR-85 | BioServUK | 10 mg | EUR 15168 |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (Californian Variant, 10mg) |
SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 100ug) |
|||
BSV-COV-PR-79 | BioServUK | 100 ug | EUR 620 |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 100ug) |
SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 1mg) |
|||
BSV-COV-PR-86 | BioServUK | 1 mg | EUR 3792 |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 1mg) |
SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 10mg) |
|||
BSV-COV-PR-87 | BioServUK | 10 mg | EUR 15168 |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 10mg) |
SARS-CoV-2 full-length Trimeric Spike Antigen (South African Variant, 100ug) |
|||
BSV-COV-PR-61 | BioServUK | 100 ug | EUR 620 |
Description: SARS-CoV-2 full-length Trimeric Spike Recombinant Protein (South African Variant, 100ug) |
SARS-CoV-2 full-length Trimeric Spike Antigen (South African Variant, 1mg) |
|||
BSV-COV-PR-63 | BioServUK | 1mg | EUR 3792 |
Description: SARS-CoV-2 full-length Trimeric Spike Recombinant Protein (South African Variant, >1mg) |
SARS-CoV-2 full-length Trimeric Spike Antigen (South African Variant, 10mg) |
|||
BSV-COV-PR-88 | BioServUK | 10 mg | EUR 15168 |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (South African Variant, 10mg) |
SARS-CoV-2 (B.1.351) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC31963-100 | The Native Antigen Company | 0.1 | EUR 636.6 |
Description: SARS-CoV-2 Spike protein, South African variant of concern. Relative to Wuhan-Hu-1 contains following amino acid changes: L18F, D80A, D215G, del242-244, K417N, E484K, N501Y, D614G, A701V. The protein contains six proline amino acid changes (commonly known as Hexapro) to stabilize it in a trimeric pre-fusion state. The furin cleavage site has been altered to 'SRAS' and deactivated. |
SARS-CoV-2 (B.1.351) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC31963-500 | The Native Antigen Company | 0.5 | EUR 2421.37 |
Description: SARS-CoV-2 Spike protein, South African variant of concern. Relative to Wuhan-Hu-1 contains following amino acid changes: L18F, D80A, D215G, del242-244, K417N, E484K, N501Y, D614G, A701V. The protein contains six proline amino acid changes (commonly known as Hexapro) to stabilize it in a trimeric pre-fusion state. The furin cleavage site has been altered to 'SRAS' and deactivated. |
SARS-CoV-2 full-length Trimeric Spike Antigen MultiPack (7 Variants & Wild 1mg each_) |
|||
BSV-COV-PR-MP-1 | BioServUK | 1 mg | EUR 18960 |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen MultiPack (7 Variants & Wild 1mg each_) |
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC32008-100 | The Native Antigen Company | 0.1 | EUR 636.6 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. |
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC32008-300 | The Native Antigen Company | 0.3 | EUR 565.87 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. |
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC32008-500 | The Native Antigen Company | 0.5 | EUR 2421.37 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. |
SARS-CoV-2 (Omicron BA.4/BA.5) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC32026-100 | The Native Antigen Company | 0.1 | EUR 636.6 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: T19I, del24-26, A27S, del69-70, G139D, E154G, del155-156, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, L452R, T478K, E484Q, F486V, P499R, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. |